| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |